Renal Cancer - Results from #260

Imaging modalities for characterising T1 renal tumours: A systematic review and meta-analysis of diagnostic accuracy. July 19, 2024

AVEO Oncology, an LG Chem company, Announces Phase 3 Renal Cell Carcinoma Clinical Trial (TiNivo-2) Results July 18, 2024

Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma. July 18, 2024

Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma. July 18, 2024

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. July 17, 2024

Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy. July 17, 2024

Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations. July 16, 2024

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma. July 16, 2024

Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient with Renal Squamous Cell Cancer. July 16, 2024

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma. July 15, 2024

Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma. July 15, 2024

Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi-institutional analysis. July 12, 2024

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney. July 12, 2024

Comparison of the Efficacy and Safety of Nivolumab Plus Cabozantinib versus Sunitinib in the Treatment of Elderly Patients with Advanced Clear Cell Renal Cell Carcinoma. July 11, 2024

High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and grades. July 11, 2024

Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma. July 10, 2024

Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell Carcinoma. July 10, 2024

Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. July 10, 2024

Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. July 9, 2024

Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. July 9, 2024

Page 14 of 456